Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
IPW - iPower Inc - Stock Price Chart
TickerIPW [NASD]
CompanyiPower Inc
CountryUSA
IndustryInternet Retail
Market Cap12.08MEPS (ttm)-0.26
P/E-EPS this Y50.37%
Forward P/E-EPS next Y75.00%
PEG-EPS past 5Y-
P/S0.14EPS next 5Y-
P/B0.68EPS Q/Q41.86%
Dividend-Sales Q/Q-12.75%
Insider Own63.36%Inst Own2.73%
Insider Trans0.00%Inst Trans-31.28%
Short Float0.03%EarningsFeb 14/a
Analyst Recom1.00Target Price1.00
Avg Volume15.99K52W Range0.42 - 1.45
iPower, Inc. engages in the online retail and supply of consumer home, garden, in-home farming, pet, and wellbeing products. It sells its brands such as Simple Deluxe, YSSOA, Zenhydro, Flourish, iPOWER, iFarm, FluffyDream, ScratchMe, and HealSmart through zenhydro.com, simpledeluxe.com, and various third-party online platforms. The company offers grow light systems, advanced heating, ventilation and air conditioning (HVAC) systems, water pumps, heaters, chillers and filters, nutrient and fertilizer delivery systems, and various growing media typically made from soil, rock wool or coconut fiber. It also provides home goods supplies including commercial fans, floor and wall fans, storage and shelving units, and chairs. The company was founded by Chenlong Tan and Allan Huang on April 11, 2018 and is headquartered in Rancho Cucamonga, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Vassily KevinChief Financial OfficerJun 02 '23Buy0.685,0003,40022,000Jun 02 04:54 PM
TAN CHENLONGChief Executive OfficerJun 01 '23Buy0.6810,0006,7908,043,334Jun 02 04:20 PM
Vassily KevinChief Financial OfficerJun 01 '23Buy0.685,0003,39517,000Jun 02 04:54 PM
TAN CHENLONGChief Executive OfficerMay 31 '23Buy0.6610,0006,5608,033,334Jun 02 04:20 PM
MGX - Metagenomi Inc. - Stock Price Chart
TickerMGX [NASD]
CompanyMetagenomi Inc.
CountryUSA
IndustryBiotechnology
Market Cap296.76MEPS (ttm)-
P/E-EPS this Y85.68%
Forward P/E-EPS next Y4.79%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own49.18%Inst Own0.00%
Insider Trans5.13%Inst Trans-
Short Float5.23%EarningsMar 28/b
Analyst Recom1.00Target Price21.20
Avg Volume227.73K52W Range8.10 - 12.74
Metagenomi, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit-ing toolbox, ther-a-peu-tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novo Holdings A/S10% OwnerFeb 13 '24Buy15.00800,00012,000,0001,739,175Feb 15 08:38 PM
Novo Holdings A/S10% OwnerFeb 09 '24Buy10.25100,0001,025,000100,000Feb 15 08:38 PM
AVBP - ArriVent BioPharma Inc. - Stock Price Chart
TickerAVBP [NASD, RUT]
CompanyArriVent BioPharma Inc.
CountryUSA
IndustryBiotechnology
Market Cap509.72MEPS (ttm)-
P/E-EPS this Y89.82%
Forward P/E-EPS next Y26.98%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-80.05%
Dividend-Sales Q/Q-
Insider Own36.81%Inst Own18.60%
Insider Trans18.09%Inst Trans-
Short Float3.47%EarningsMar 28/a
Analyst Recom1.00Target Price31.50
Avg Volume234.60K52W Range15.50 - 25.95
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HILLHOUSE INVESTMENT MANAGEMEN10% OwnerJan 30 '24Buy18.00555,5559,999,9904,484,672Feb 01 04:47 PM
HEALY JAMESDirectorJan 30 '24Buy18.00444,4447,999,9921,696,752Jan 31 04:10 PM
GORDON CARL LDirectorJan 30 '24Buy18.00444,4447,999,9921,513,664Jan 31 04:11 PM
ORBIMED ADVISORS LLCDirectorJan 30 '24Buy18.00444,4447,999,9921,513,664Jan 31 04:12 PM
FCEL - Fuelcell Energy Inc - Stock Price Chart
TickerFCEL [NASD, RUT]
CompanyFuelcell Energy Inc
CountryUSA
IndustryElectrical Equipment & Parts
Market Cap428.99MEPS (ttm)-0.26
P/E-EPS this Y-5.40%
Forward P/E-EPS next Y6.70%
PEG-EPS past 5Y50.65%
P/S4.16EPS next 5Y15.00%
P/B0.65EPS Q/Q4.80%
Dividend-Sales Q/Q-54.98%
Insider Own0.34%Inst Own43.95%
Insider Trans0.00%Inst Trans4.18%
Short Float19.71%EarningsMar 07/b
Analyst Recom3.10Target Price1.47
Avg Volume12.06M52W Range0.98 - 2.94
FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feasel MarkEVP & Ch. Commercial OfficerMar 25 '24Option Exercise0.0083,4930164,343Mar 27 04:34 PM
Dolger JoshuaGeneral Counsel & Corp SecDec 11 '23Option Exercise0.004,710021,311Dec 13 04:44 PM
Few JasonCEODec 11 '23Option Exercise0.0020,8330841,954Dec 13 04:47 PM
Bishop Michael S.EVP, TREASURER & CFODec 11 '23Option Exercise0.006,5220175,579Dec 13 04:48 PM
Feasel MarkEVP & Ch. Commercial OfficerDec 11 '23Option Exercise0.006,522083,310Dec 13 04:42 PM
SLRN - Acelyrin Inc - Stock Price Chart
TickerSLRN [NASD, RUT]
CompanyAcelyrin Inc
CountryUSA
IndustryBiotechnology
Market Cap468.53MEPS (ttm)-3.92
P/E-EPS this Y24.27%
Forward P/E-EPS next Y-15.86%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.71EPS Q/Q-526.06%
Dividend-Sales Q/Q-
Insider Own37.98%Inst Own68.13%
Insider Trans-0.10%Inst Trans-
Short Float13.03%EarningsMar 28/a
Analyst Recom1.40Target Price31.00
Avg Volume1.29M52W Range4.98 - 29.88
ACELYRIN, Inc. operates as a biopharma company. It engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines. The company was founded by Shao-Lee Lin on July 27, 2020 and is headquartered in Agoura Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lin Shao-LeeChief Executive OfficerApr 01 '24Sale6.639,96166,0241,577,374Apr 03 06:18 PM
Lin Shao-LeeChief Executive OfficerFeb 20 '24Sale7.6015,701119,4031,587,335Feb 22 07:04 PM
Lin Shao-LeeChief Executive OfficerJan 02 '24Sale7.4110,69179,1881,603,036Jan 04 06:09 PM
Westlake BioPartners Fund II, 10% OwnerMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:16 PM
SEIDENBERG BETH CDirectorMay 09 '23Buy18.001,250,00022,500,0009,790,729May 11 09:13 PM
CHPT - ChargePoint Holdings Inc - Stock Price Chart
TickerCHPT [NYSE]
CompanyChargePoint Holdings Inc
CountryUSA
IndustrySpecialty Retail
Market Cap589.40MEPS (ttm)-1.23
P/E-EPS this Y49.02%
Forward P/E-EPS next Y37.57%
PEG-EPS past 5Y-149.12%
P/S1.16EPS next 5Y-
P/B1.79EPS Q/Q0.70%
Dividend-Sales Q/Q-24.21%
Insider Own12.88%Inst Own32.61%
Insider Trans-3.07%Inst Trans-0.40%
Short Float31.36%EarningsMar 05/a
Analyst Recom2.52Target Price3.12
Avg Volume14.18M52W Range1.40 - 10.10
ChargePoint Holdings, Inc. operates as an electric vehicle charging network provider. It designs, develops and markets networked electric vehicle charging system infrastructure and its Cloud Services enable consumers the ability to locate, reserve, authenticate and transact electric vehicle charging sessions. The firm provides an open platform providing real-time information about charging sessions and control, support and management of the networked charging systems. This network provides multiple web-based portals for charging system owners, fleet managers, drivers and utilities. The company was founded in 2007 and is headquartered in Campbell, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wilmer RichardPresident and CEOMar 21 '24Sale1.8725,37647,4532,359,462Mar 21 09:50 PM
Khetani MansiInterim CFOMar 21 '24Sale1.8719,03535,595421,500Mar 21 09:50 PM
Singh Jagdeep CACCXOMar 21 '24Sale1.879,48517,737484,503Mar 21 09:50 PM
Gerdes HenrikChief Accounting OfficerMar 21 '24Sale1.875,60710,485220,115Mar 21 09:50 PM
Chavez RebeccaCLO and Corp SecretaryMar 21 '24Sale1.874,8289,028642,690Mar 21 09:51 PM
TSE - Trinseo PLC - Stock Price Chart
TickerTSE [NYSE, RUT]
CompanyTrinseo PLC
CountryUSA
IndustrySpecialty Chemicals
Market Cap97.32MEPS (ttm)-19.93
P/E-EPS this Y16.00%
Forward P/E-EPS next Y47.23%
PEG-EPS past 5Y-
P/S0.03EPS next 5Y30.29%
P/B-EPS Q/Q27.87%
Dividend1.45%Sales Q/Q-14.12%
Insider Own4.35%Inst Own83.14%
Insider Trans3.37%Inst Trans-5.89%
Short Float3.47%EarningsMay 08/a
Analyst Recom2.67Target Price6.00
Avg Volume398.37K52W Range2.84 - 20.97
Trinseo Plc engages in the manufacture and sale of plastics and latex binders. It operates through the following segments: Engineered Materials, Latex Binders, Base Plastics, Polystyrene, Feedstocks, and Americas Styrenics. The Engineered Materials segment produces rigid thermoplastic compounds and blends products, soft thermoplastic products, and cast and sheet products. The Latex Binders segment creates styrene-butadiene latex. The Base Plastics segment manufactures a variety of compounds and blends, the majority of which are for automotive applications. The Polystyrene segment offers a variety of general-purpose polystyrenes and high impact polystyrenes. The Feedstocks segment deals with the production of styrene monomers in order to provide secure sourcing of this key raw material to the company's other segments. The Americas Styrenics segment is composed of the operations of the company's owned joint venture with Chevron Phillips Chemical Company. The company was founded on October 8, 2021 and is headquartered in Wayne, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FARRELL MATTHEWDirectorDec 14 '23Buy7.2150,000360,50079,510Dec 18 04:05 PM
Stasse David PhillipEVP AND CFOSep 14 '23Buy8.8915,000133,350105,552Sep 18 01:53 PM
Desmond Jeanmarie F.DirectorSep 13 '23Buy7.942,50019,85019,128Sep 13 03:01 PM
Chaclas Angelo N.SVP, CLO, CCO & CORP. SEC.Sep 12 '23Buy8.0720,000161,40088,508Sep 13 02:57 PM
BOZICH FRANK ACEO AND PRESIDENTSep 12 '23Buy8.078,00064,560192,653Sep 13 02:52 PM
CYTO - Altamira Therapeutics Ltd - Stock Price Chart
TickerCYTO [NASD]
CompanyAltamira Therapeutics Ltd
CountryBermuda
IndustryBiotechnology
Market Cap2.38MEPS (ttm)-
P/E-EPS this Y73.72%
Forward P/E-EPS next Y29.05%
PEG-EPS past 5Y50.52%
P/S-EPS next 5Y-
P/B-EPS Q/Q87.98%
Dividend-Sales Q/Q-
Insider Own0.06%Inst Own0.49%
Insider Trans0.00%Inst Trans19.68%
Short Float28.13%EarningsApr 10/b
Analyst Recom1.00Target Price287.34
Avg Volume1.17M52W Range1.48 - 29.00
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
TVGN - Tevogen Bio Holdings Inc. - Stock Price Chart
TickerTVGN [NASD]
CompanyTevogen Bio Holdings Inc.
CountryUSA
IndustryBiotechnology
Market Cap33.62MEPS (ttm)0.07
P/E30.89EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.41EPS Q/Q-152.38%
Dividend-Sales Q/Q-
Insider Own6.10%Inst Own11.03%
Insider Trans0.00%Inst Trans0.47%
Short Float0.08%Earnings-
Analyst Recom-Target Price-
Avg Volume355.04K52W Range2.22 - 21.09
Apr-11-24 08:05AM Tevogen Bio's Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers (GlobeNewswire)
Apr-03-24 08:05AM Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development (GlobeNewswire) -11.19%
Mar-28-24 08:05AM Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price (GlobeNewswire) +8.05%
Mar-27-24 09:20AM Tevogen Bio Announces Series A-1 Preferred Stock Investment (GlobeNewswire) -10.65%
Mar-20-24 07:00AM Tevogen Bio Reports Its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant (Business Wire)
Mar-05-24 08:00AM Tevogen Bio Holdings Congratulates its Board Member and Esteemed Global Safety Management Expert, Victor Sordillo, on His appointment as Managing Director of Risk Advisory Services at Verita (Business Wire)
Feb-27-24 04:39PM Mittul Mehta, Head of Tevogen's Artificial Intelligence Initiative Tevogen.ai, Emphasizes Importance of Proactive Talent Development for Biopharmaceutical Sector to Allow Rapid Adoption of AI (Business Wire)
Feb-21-24 07:00AM Cell Therapy Company Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment (Business Wire)
Feb-17-24 12:17AM Cell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq: TVGN) Rings Opening Bell at Nasdaq Exchange on February 15th, 2024, Begins Public Trading on the Open Market (Business Wire)
Feb-15-24 09:25AM Tevogen Bio Announces $8 Million Equity Investment (Business Wire) +121.73%
Tevogen Bio Holdings, Inc. is a clinical-stage specialty immunotherapy company. It develops off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company was founded on February 14, 2024 and is headquartered in Warren, NJ.
NA - Nano Labs Ltd - Stock Price Chart
TickerNA [NASD]
CompanyNano Labs Ltd
CountryChina
IndustrySemiconductors
Market Cap56.51MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own0.00%
Insider Trans-Inst Trans66.67%
Short Float0.16%EarningsMar 18/b
Analyst Recom-Target Price-
Avg Volume813.43K52W Range0.52 - 5.94
Nano Labs Ltd. is a holding company, which engages in design and product solution provision of fabless integrated circuit. It offers high throughput computing chips, high performance computing chips, distributed computing and storage solutions, smart network interface cards, vision computing chips, and distributed rendering. The company was founded in July, 2019 and is headquartered in Hangzhou, China.
1234567891020